Melanoma Clinical Trials

Showing 61-80 of 1,477 trials

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

NCT03804255

This trial assesses current biomarker testing practices for common solid cancers in precision oncology in the community setting. Cancer biomarkers are used for diagnosing the disease, determining prognosis, predicting response to a targeted therapy, or monitoring response to therapy. Testing quality, including accuracy and timeliness, is imperative for correct disease prognosis and identification of patients who may or may not benefit from a targeted therapy. Assessing current biomarker testing practices may help doctors identify gaps and variations in testing as well as on potential ?best practices? that may be informative and generalizable to community oncology programs.

Breast CarcinomaColorectal CarcinomaCommunity Practice+3 more

ECOG-ACRIN Cancer Research GroupStarted Jan 2019

Chicago, Illinois, United States

RECRUITINGNA

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Breast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more

Eastern Cooperative Oncology Group400 participantsStarted Nov 2021

Fairbanks, Alaska, United States • Kingman, Arizona, United States • Phoenix, Arizona, United States +344 more locations

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Related Searches

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

iSITE: Investigation of Somatic Alterations in Tumours of the Eye

The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care

Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis

NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Screening for Brain Metastases

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Dinaciclib in Treating Patients With Stage IV Melanoma

Harvesting Cells for Experimental Cancer Treatments

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients